Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
After MDMA and psilocybine has been supplied, you have specific responsibilities.
You must:
- maintain accurate records
- monitor product use
- report supply data every six months
- report adverse events.
We oversee these activities to ensure that unapproved therapeutic goods are supplied appropriately.
Understanding and fulfilling your obligations is crucial for maintaining compliance.
You must meet certain obligations to legally supply therapeutic goods in Australia. This section contains guidance and information specific to unapproved therapeutic goods. You may also have to meet obligations that apply to all unapproved therapeutic goods and all products.